Secukinumab real world drug retention compared to TNF-alpha inhibitors in psoriatic arthritis.

CONCLUSIONS: This multicentre real-world study demonstrated that secukinumab had a drug retention comparable to TNFi. Secukinumab had a better drug retention than TNFi among biologic-experienced patients. IL-17 inhibition is an effective mechanism of action to treat PsA in real life. PMID: 33427613 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33427613?dopt=Abstract

Source: Clinical and Experimental Rheumatology - January 13, 2021 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research